06 LC
33 1220S
House
Bill 1054 (COMMITTEE SUBSTITUTE)
By:
Representatives Stephens of the
164th,
Parham of the
141st,
Parrish of the
156th,
Graves of the
137th,
and Carter of the
159th
A
BILL TO BE ENTITLED
AN ACT
AN ACT
To
amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating
to controlled substances, so as to change certain provisions relating to
Schedule I controlled substances; to change certain provisions relating to
Schedule IV controlled substances; to change certain provisions relating to the
definition of the term "dangerous drug"; to provide an effective date; to repeal
conflicting laws; and for other purposes.
BE
IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:
SECTION
1.
Chapter
13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled
substances, is amended in Code Section 16-13-25, relating to Schedule I
controlled substances, by striking subparagraphs (O), (Z), and (SS) of paragraph
(3) and inserting in their respective places the following:
"(O)
Psilocyn
(Psilocin);"
"(Z)
3, 4-Methylenedioxymethamphetamine
(MDMA);"
"(SS)
MDMA (3, 4
Methylene Dioxymethamphetamine)
Reserved;"
SECTION
2.
Said
chapter is further amended in Code Section 16-13-28, relating to Schedule IV
controlled substances, by striking paragraph (33) and inserting its place the
following:
"(33)
Zolpidem;
(34)
Zopiclone, and all salts, isomers, and salts of isomers
thereof."
SECTION
3.
Said
chapter is further amended in Code Section 16-13-71, relating to the definition
of dangerous drug, by striking paragraphs (116.05), (116.1), (193.5), (515),
(663.1), and (663.75) in subsection (b) and inserting in their respective places
the following:
"(116.05)
Buprenorphine
Reserved;"
"(116.1)
Buproprion
Bupropion;"
"(193.5)
Cinacalet
Cinacalcet;"
"(515)
Levallorphan
Reserved;"
"(663.1)
Olmesartain
Olmesartan;"
"(663.75)
Orlistat
– See
exceptions;"
SECTION
4.
Said
chapter is further amended in Code Section 16-13-71, relating to the definition
of dangerous drug, by inserting new paragraphs in subsection (b) to read as
follows:
"(13.53)
Adalimumab;"
"(108.5)
Bromfenac;"
"(243.5)
Deferasirox;"
"(332.85)
Entecavir;"
"(380.6)
Exenatide;"
"(409.8)
Galsulfase;"
"(464.7)
Iloprost;"
"(513.7)
Lenalidomide;"
"(544.5)
Mecasermin;"
"(616.05)
Micafungin;"
"(638.75)
Nelarabine;"
"(640.1)
Nepafenac;"
"(681.4)
Palifermin;"
"(692.51)
Pegfilgrastin;"
"(692.515)
Peginterferon;"
"(769.3)
Pramlintide;"
"(772.5)
Pregabalin;"
"(831.04)
Ramelteon;"
"(843.2)
Risedronate;"
"(966.3)
Tigecycline;"
"(967.57)
Tipranavir;"
SECTION
5.
Said
chapter is further amended in Code Section 16-13-71, relating to the definition
of dangerous drug, by inserting a new paragraph in subsection (c) to read as
follows:
"(16.95)
Orlistat – when a single dosage unit is 60 mg. or
less;"
SECTION
6.
This
Act shall become effective upon its approval by the Governor or upon its
becoming law without such approval.
SECTION
7.
All
laws and parts of laws in conflict with this Act are repealed.